Showing results (261-270 of 496) with videos related to
Sort By:
Pageof 50
Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.Plos Pathogens|October 13, 2020
Mining for humoral correlates of HIV control and latent reservoir sizeJishnu Das, Anush Devadhasan, Caitlyn Linde, et al.Frontiers in Immunology|September 10, 2021
Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LSMartina S Wesley, Kelvin T Chiong, Kelly E Seaton, et al.Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19Dan H Barouch, Kathryn E Stephenson, Jerald Sadoff, et al.Nature Medicine|July 22, 2009
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien, Jinyan Liu, Sharon L King, et al.Journal of Virology|June 26, 2009
Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeysDan H Barouch, Jinyan Liu, Diana M Lynch, et al.Iscience|April 24, 2024
B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.SCatherine Jacob-Dolan, Michelle Lifton, Olivia C Powers, et al.Biorxiv : the Preprint Server for Biology|August 4, 2020
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 ReceptorPeng Zhao, Jeremy L Praissman, Oliver C Grant, et al.Cell Host & Microbe|August 26, 2020
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 ReceptorPeng Zhao, Jeremy L Praissman, Oliver C Grant, et al.Biorxiv : the Preprint Server for Biology|June 23, 2021
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2Lisa H Tostanoski, Lisa E Gralinski, David R Martinez, et al.Pageof 50